LOADING
Comparing NVIDIA Corporation (NVDA) and AbbVie Inc (ABBV) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | NVDA | ABBV |
|---|---|---|
| Price | $228.02 | $210.06 |
| Change Today | -3.27% | -0.34% |
| Market Cap | $5.47T | $368.4B |
| P/E Ratio | 46.1 | 102.2 |
| Forward P/E | 26.5 | 14.1 |
| PEG Ratio | 0.68 | 0.56 |
| EPS | $4.90 | $2.04 |
| Revenue Growth (YoY) | 73.2% | 12.4% |
| Profit Margin | 55.6% | 5.8% |
| Return on Equity | 101.5% | 62.3% |
| Dividend Yield | 0.02% | 3.24% |
| Beta | 2.24 | 0.30 |
| 52-Week High | $236.54 | $239.13 |
| 52-Week Low | $129.13 | $174.56 |
| Volume | 1.5M | 67K |
NVIDIA Corporation is the larger company by market capitalization. NVIDIA Corporation trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AbbVie Inc offers a higher dividend yield for income investors. NVIDIA Corporation has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.